Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Why some dogs do not respond to epilepsy treatments
border collie
Past research has shown around a third of dogs do not respond to anti-epilepsy drugs.
Breed and sex impact the effectiveness of AEDs, says RVC

New research has shed light on why around a third of dogs do not respond to epilepsy treatments.

Sex, breed and frequency of seizures all affect the likelihood of achieving remission, according to specialists from the Royal Veterinary College (RVC).

Epilepsy affects around 50,000 dogs and 600,000 people in the UK, making it the most common chronic neurological condition found in both dogs and humans. Research has shown anti-epilepsy drugs (AEDs) fail to reduce seizures by 50 per cent in a third of cases.

RVC researchers sought to find out why, using patient data from six years of medical history, taken from the college's small animal referral hospital.

Just 14 per cent of the dogs studied were in seizure-free remission at the point of follow up.

The findings, which will be published in the academic journal PLOS ONE, show that male dogs were less likely than female dogs to become seizure-free while receiving AED treatment.

Border collies and German shepherds were also found to be significantly less likely to respond to treatment. Past studies have looked at the impact of AEDs on different dog types, but the RVC was able to explore how this affects a wider variety of breeds.

Researchers say they also discovered that the likelihood of achieving remission is not affected by the number of seizures experienced before treatment begins. Traditionally in human medicine, treatment is given immediately after the onset of epilepsy.

Rowena Packer, co-author of the study and clinical investigations research assistant at the RVC, said managing owners' expectations of drug treatments for epilepsy is important.

"In its worst form canine epilepsy can be life threatening to dogs, but it is a dog's long-term quality of life that is most affected. It can also take a toll on the owners who have to manage this unpredictable, uncontrollable condition."

Lead author Professor Holger Volk, specialist in neurology and neurosurgery and clinical director of the RVC's small animal referral clinic, added: "Drug treatments can be successful in reducing seizures, but it is important to note that consistent remission is difficult to attain."

Researchers say further study of AED treatment in dogs could even improve understanding of epilepsy in humans.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.